Growth factor -induced intracellular calcium signals in endothelial cells regulate cytosolic and nuclear events involved in the angiogenic process. Among the intracellular messengers released after proangiogenic stimulation, arachidonic acid (AA) plays a key role and its effects are strictly related to calcium homeostasis and cell proliferation. Here, we studied AA-induced intracellular calcium signals in endothelial cells derived from human breast carcinomas (B-TEC). AA promotes B-TEC proliferation and organization of vessel-like structures in vitro. The effect is directly mediated by the fatty acid without a significant contribution of its metabolites. AA induces Ca 2+
Introduction
Intracellular calcium signals are a highly conserved and ubiquitous mode for the control of cell survival, proliferation, motility, apoptosis, and differentiation (1, 2) . Recently, clear evidence has been presented for a role of Ca 2+ in the regulation of angiogenesis in vivo. Blockade of calcium entry resulted in a reduction in the motility, adhesion, and proliferation of activated endothelial cells (2) .
Intracellular calcium dynamics are specifically modulated by extracellular agents such as vascular endothelial growth factors (VEGF) and fibroblast growth factors (FGF; refs. [2] [3] [4] [5] . Therefore, regulation of changes in intracellular concentrations ([Ca 2+ ] i ) is a potent putative molecular target for angiogenesis interference.
Different lines of evidence show that key angiogenic growth factors, such as basic FGF and VEGF, through their specific binding to tyrosine kinase receptors, trigger a signaling cascade involving autophosphorylation, activation of PLC-g, and Ca 2+ entry dependent (store-operated calcium entry or SOCE) or independent from the intracellular stores release (non -storeoperated calcium entry or NSOCE; refs. [6] [7] [8] [9] [10] .
Among the second messengers proposed to play a role in NSOCE activation, arachidonic acid (AA) itself and some of its metabolites induce calcium increases directly correlated with cell proliferation in different cell types, including endothelial cells (11) (12) (13) . Although several reports have implicated AA metabolites in the control of the angiogenic process with a key role in cell proliferation, cell motility, and angiogenic process (14) (15) (16) , little is known about the direct role of AA. The direct effect of AA, independent of its metabolites, has been revealed via two major strategies: the pharmacologic inhibition of cyclooxygenase, lypooxygenase, and cytochrome P450 monooxygenase (using indomethacin, nordihydroguaiaretic acid, econazole derivatives, and other compounds, some of which are highly aspecific) or the use of 5,8,11,14-eicosatetraynoic acid (ETYA), an AA analogue not metabolized by the enzymes cited above, able to mimic at least partially AA-dependent calcium entry. Recently, we showed that AA induces a sustained NSOCE involved in the control of proliferation. It is probably due to more than one type of calcium channel, whose molecular nature is not known in bovine aortic endothelial cells (11, 12, 17) .
A number of compounds inhibit calcium entry, including carboxyamidotriazole (CAI), an anti-invasive and antiangiogenic agent that inhibits calcium-mediated signal transduction in tumor cells and endothelial cells by blocking agonistactivated calcium entry (5, 18) . The blockage by CAI results in inhibition of endothelial cell attachment to extracellular matrix substrate, migration, and proliferation in vivo and in vitro (17, (19) (20) (21) . Currently, CAI is under investigation as an orally administered tumoristatic and antiangiogenic agent in clinical phase I and phase II trials (22) (23) (24) (25) (26) (27) .
On the other hand, blood vessels in tumors differ from normal vessels by their altered morphology, blood flow, permeability, and abnormalities in pericytes and in the basement membrane (28) (29) (30) (31) . Recent evidence indicates that tumor-derived endothelial cells (TEC) themselves possess a distinct and unique phenotype. TECs are different from normal vessel endothelial cells at molecular and functional levels (30, 32, 33) . Recently, tumor-derived endothelial cells obtained from breast carcinomas (B-TEC) have been established and characterized (34, 35) . These cells display an immature proangiogenic phenotype with enhanced proliferation, motility, and capillary-like tube formation compared with ''normal'' endothelial cells. They represent an interesting model to be studied to verify the role of different factors in the tumoral angiogenic process.
In the present study, we investigated the role of AA-induced Ca 
Results

AA Induces Tubulogenesis and Proliferation in B-TECs
In vitro
To investigate the role of AA on B-TEC proliferation, cells were starved in the presence of low serum concentration (1%) for 24 hours and subsequently incubated for an additional 24 hours in the presence of 5 Amol/L AA or 5 Amol/L ETYA. Figure 1 shows that 5 Amol/L AA stimulation significantly increases B-TECs proliferation (n = 4 experiments). This effect is directly mediated by AA without a significant contribution of its metabolites: application of 5 Amol/L ETYA (n = 4 experiments), a nonmetabolized analogue of AA, induces a similar increase on B-TEC proliferation over control (n = 4 experiments). Interestingly, 1 Amol/L ATP, known to have vasoactive effects, promotes again a significant increase in B-TEC proliferation ( Fig. 1 ; n = 3 experiments). One-way ANOVA and the Student-Newman-Keuls post hoc test for each single experiment were used as scoring methods. The level of significance was P < 0.05. Taken together, the proliferation rate is 34 F 3.5% for AA-, 23 F 7.6% for ETYA-, and 30 F 12.4% for ATP-induced B-TEC proliferation over control.
The role of AA in tubule formation of tumor-derived endothelial cells was investigated by tubulogenesis assays in vitro. Quiescent B-TECs were plated on 24-well plates Fig. 2A and B). In contrast, 1 Amol/L ATP is not able to induce any significant increase in tubulogenesis compared with control (124 F 26 Am tube length Â field, n = 3 experiments, Fig. 2B ). Again, one-way ANOVA and the Student-Newman-Keuls post hoc test for each single experiment were used as scoring methods (P < 0.05). The data show that 5 Amol/L AA is able to enhance both B-TEC cell proliferation as well as tubule formation in vitro, without a significant contribution of its metabolites. ATP, 1 Amol/L, enhances B-TEC cell proliferation but fails to increase tubule formation. 50 1.7 Amol/L, respectively) in a dose-dependent manner ( Fig. 5B and D) . Additionally, we did experiments in Ca 2+ -free medium to exclude Ca 2+ entry. Both AA and ETYA failed to induce any Ca 2+ i signal (87.5%, n = 40; 97.5%, n = 80 cells respectively). In contrast, 100 Amol/L ATP application induces a transient Ca contribution of its metabolites and (b) completely dependent from extracellular Ca 2+ . Due to the ability of AA to inhibit SOCE in several cell types (36, 37), we tested if this effect was present in B-TECs. Application of 5 Amol/L AA or 5 Amol/L ETYA on cells pretreated with 2 Amol/L thapsigargin for 10 minutes, a widely used SERCA inhibitor that irreversibly depletes intracellular calcium stores and triggers store-dependent calcium entry, induces a strong and reversible decrease of calcium levels in the great majority the cells (89% n = 56 cells and 78% n = 41 cells, Fig. 6A and B) ; subsequent application of 100 Amol/L ATP fails to induce any signal showing the ability of thapsigargin to inhibit Ca 2+ release from intracellular stores. A similar inhibitory effect is observed when 5 Amol/L AA or 5 Amol/L ETYA are applied during the plateau phase of 100 Amol/L ATP-induced Ca 2+ i signals, mainly due to SOCE as previously described (84%, n = 43 cells and 100%, n = 63 cells respectively; Fig. 6C and D).
AA-Induced Ca
Blocking Ca
2+ Entry Prevents Tubulogenesis In vitro and AA-Induced Ca 2+ Signals of B-TECs CAI was used to study the role of Ca 2+ entry on tubule formation of tumor-derived endothelial cells. B-TEC capillarylike structure formation is inhibited by CAI in a dose-dependent manner (Fig. 7B) . The minimal effective dose on low-seruminduced tubulogenesis is 1 Amol/L CAI (109 F 15 Am tube length versus 123 F 12 Am tube length in control, n = 3 experiments). A specific inhibition on AA-induced tubulogenesis (181 F 14 Am tube length, n = 3 experiments) is observed at 0.1 Amol/L CAI (129 F 15 Am tube length, n = 3 experiments; Fig. 7A and B) . One-way ANOVA and the Student-Newman-Keuls post hoc test for each single experiment were used as scoring methods (P < 0.05).
B-TEC preincubation with 0.1 Amol/L CAI for 10 minutes significantly inhibits peak amplitude of AA-induced Ca 2+ entry by 80%: from DR [R increment (340/380)] of 0.025 F 0.009, n = 50 cells, to 0.005 F 0.003, n = 60 cells, in the presence of CAI (Fig. 8A and B) as estimated by one-way ANOVA and the Student-Newman-Keuls post hoc test (P < 0.001). Preincubation with 10 Amol/L CAI completely abolishes AA-induced Ca 2+ entry in 95% of the cells analyzed (n = 61 cells, data not shown).
Acute application of 0.1 Amol/L CAI partially and reversibly reduces AA-induced Ca responses are independent from its metabolites and completely due to Ca 2+ entry. B-TECs were plated on gelatin-coated glass coverslips and imaged using methods outlined in Fig. 3 The data show a role for AA-induced Ca 2+ entry in B-TEC tubulogenesis in vitro.
Discussion
AA, preferentially through its metabolites, plays a key role in different phases of the angiogenic process, including endothelial cell proliferation (38) (39) (40) . We previously showed that AA promotes cell proliferation in bovine aortic endothelial cells. This effect is at least partially due to AA itself (11) although a role for eicosanoids of cyclooxygenase and lypooxygenase pathway has been proposed (17) . Here, we show that both AA and ETYA induce cell proliferation in BTECs in accordance with a role for the fatty acid both in normal and tumor-derived endothelial cells. Interestingly, B-TEC proliferation is also significantly enhanced by ATP application; even if ATP has been shown to be mainly implicated in the control of short-term events associated with the control of vascular tone (41) , different studies suggest a role for ATP in long-term vascular events (such as cell proliferation in different endothelial cell types; refs. 42, 43) .
Besides a proliferative effect, AA enhances B-TEC organization into vessel-like structures on Matrigel. This evidence is in agreement with observation from normal endothelial cells (14, 44) . In particular, a role for cyclooxygenase and lypooxygenase metabolites has been proposed in the angiogenic process induced by basic FGF or VEGF (45, 46) . Although we cannot exclude a role for AA metabolites, the mimicking effect of ETYA points out a direct role for AA in the organization of in vitro angiogenesis in tumor-derived endothelial cells. In contrast, low doses of ATP fail to induce any effect on B-TEC tubule length, in accordance with its main role as a vasoactive compound (41) .
Different angiogenic factors (including basic FGF and VEGF) able to induce the release of AA exert their biological effect by increasing [Ca 2+ ] i in different cell types, including endothelial cells (5, 11, 40) . To test the hypothesis of a role for Ca i responses both in early and organized tubules in vitro. In contrast to AA, ATP binding to its specific G-protein -coupled P2Y receptors triggers a strong and fast Ca 2+ release from intracellular stores via IP3 production, followed by a sustained store-operated Ca 2+ entry (47) . The lack of a tubulogenic effect and the unaltered ATP-induced Ca 2+ i signals during the capillary-like network development support the hypothesis of a specific role for AAinduced Ca 2+ i signals in the early steps of B-TEC in vitro angiogenesis. It is well known that calcium is crucial to cellular events involved in the process of angiogenesis (2); therefore, the regulation of spatial patterning resulting from amplitude, frequency, and duration of the calcium signals is essential for its intracellular signaling (48) (49) (50) .
Different angiogenic molecules could play specific roles in different stages of tumor angiogenesis. The understanding of behavior. Fura-2 dye is more sensitive for detecting ''lowintensity'' Ca 2+ i signals than Fluo-3. A signal not detectable by Fluo-3 could be detectable using a more sensible probe as Fura-2.
Although we did not provide any direct data explaining the mechanism underlying the observed AA-induced Ca 2+ i signals, the down-regulation of the signal during in vitro angiogenesis progress is likely to be associated with the channel functionality at the membrane level due to several factors. A down-regulation of the channel, either at the gene or protein level, could account for this behavior. In accordance with such a hypothesis, previous reports showed differential gene expression at different stages of in vitro angiogenesis (52) . The presence of a channel at the cell membrane must be tightly controlled to ensure correct timing and duration of signals relayed by such proteins. Activation of several channels belonging to the TRP family of channels correlates with their increased appearance at the plasma membrane (53) (54) (55) . The molecular nature of AA-activated, calcium-permeable channels in the plasma membrane is still unknown. Recently, some authors reported that members of TRP family of channels can be activated by fatty acids. In particular, TRPV1 and TRPV4 are gated by AA metabolites, and TRPV3 and TRPC4 are gated directly by AA itself (56) (57) (58) (59) . Finally, some members of the TRP family of channels are involved in growth factorinduced calcium entry with a consequent role in cell cycle progression (60, 61) .
The direct link between AA-induced angiogenesis and the role of Ca 2+ entry in this process is provided by CAI. Application of low doses of CAI completely abolishes AAinduced in vitro tubulogenesis; higher doses of this compound also block low serum -induced B-TEC capillary-like organization in accordance with previous literature (21, 62) . The high sensitivity of B-TECs to CAI is an interesting feature of the article. The dose of antiangiogenic agents is peculiar in determining the efficacy of combination therapies. CAI has been shown to exert its blocking effects starting from 1 Amol/L in normal endothelial cells (5, 17, 20) . Higher doses of CAI have antiangiogenic activity in different systems such as mouse presenting ischemic retinopathy, rat aortic ring culture, or chorioallantoic membrane (18, 20, 62) . Here, we present the first evidence of a role for CAI in tumor-derived endothelial cells showing that 0.1 Amol/L CAI specifically blocks AAinduced in vitro angiogenesis. It has to be mentioned that tumor-derived endothelial cells can be considered an additional subtype of endothelial cells presenting morphologic, functional, and structural differences from their normal counterpart (30) (31) (32) . Tumor angiogenesis relies on the molecular and structural diversity of tumor-associated vasculature; therefore, such differences provide the bases for the development of targeted therapies (63) (64) (65) . This is of particular interest considering that CAI is under phase I and phase II clinical trials for the treatment of solid tumors (22, (24) (25) (26) (27) . CAI is a nonselective blocker of nonvoltage-gated Ca 2+ channels and it has been shown to inhibit both SOCE and NSOCE (17, (66) (67) (68) . In particular, we previously showed that CAI blocks AAinduced NSOCE in normal endothelial cells (17 (11, 12) .
Another interesting feature observed in B-TECs is AA inhibition of store-operated calcium entry, induced by thapsigargin or maximal effective dose of ATP. A reciprocal regulation of AA-activated NSOCE and SOCE has been reported by several authors (36, 37, 69, 70) . It has been suggested that AA coordinates the contribution of different receptor-regulated pathways such that each is activated in a specific temporal sequence. By activating NSOCE, and simultaneously inhibiting SOCE, AA ensures that, when the extracellular stimulus is present, only the NSOCE pathway contributes to Ca 2+ entry whereas SOCE contributes only after removal of the stimulus (37) . The mechanisms underlying this phenomenon are still unclear. Some authors suggest that NO either directly or indirectly acts as a messenger downstream of AA to inhibit SOCE (70) (71) (72) . Another hypothesized mechanism is a direct interaction between AA and store-operated channel or an alteration of the lipid environment by AA (70) .
In conclusion, our study shows a critical role for AAinduced Ca 2+ entry in the angiogenic process of tumor-derived endothelial cells in vitro. Future studies will be necessary to assess AA-induced angiogenesis on tumor-derived endothelial cells in vivo.
Materials and Methods
Cell Cultures
Tumor-derived endothelial cells were obtained from breast lobular-infiltrating carcinoma (B-TEC).
Endothelial cells were isolated, using anti-CD105 antibody coupled to magnetic beads, by magnetic cell sorting using the MACS system (Miltenyi Biotec) and grown in complete EBM medium (Cambrex) supplemented with 10% FCS (Cambrex), 50 Ag/mL gentamicin (Cambrex), and 2 mmol/L glutamine (Cambrex) as previously described (34, 73) . Cells were used at passages 3 to 15. Moreover, periodically, cells were characterized by morphology and expression of a panel of endothelial antigens such as CD105, CD31, Muc-18 (CD146), CD44, and VEGFR2 (KDR; ref. 34) .
Materials
ETYA and AA were purchased from Sigma; thapsigargin was from Calbiochem; the calcium probes Fluo-3 AM and Fura-2 AM were from Molecular Probes, Inc. CAI was a kind gift from the Drug Synthesis and Chemistry Branch, National Cancer Institute, NIH (Bethesda, MD).
Unless otherwise specified, all other reagents were obtained from Sigma.
In vitro Angiogenesis Assay
In vitro formation of capillary-like structures was studied on growth factor -reduced Matrigel (BD Bioscience). B-TECs (3 Â 10 4 cells per well) were seeded onto Matrigel-coated wells in DMEM medium containing 0.25% bovine serum albumin and 5% of FCS. Cell organization onto Matrigel was periodically observed with a Nikon Diaphot inverted microscope and 
Cell Growth Assays
Proliferation of B-TECs was assessed by a colorimetric assay as previously reported (17) . Briefly, B-TECs were plated on gelatin-coated plastic in 96-well plates (Falcon, Becton Dickinson) in EBM containing 10% FCS at a density of 800 cells per well (six wells for each condition). After 18 h, the medium was replaced with DMEM + 1% FCS to slow the proliferation rate for 24 h, then it was replaced again with DMEM + 1% FCS, either alone (basal condition) or supplemented with different agonists. One day later, the endothelial cell number was estimated. Cells were fixed in 2.5% glutaraldehyde in PBS for 20 min, then stained with crystal violet (0.1% in 20% methanol), solubilized in acetic acid (10%, v/v), and read at 595 nm in a Microplate Reader (model 550, Bio-Rad). For each experiment, a calibration curve was set up with a known number of cells and a linear correlation between absorbance and cell number was established, so that for each condition the mean number of cells F SD was assessed.
Calcium Imaging
Confocal fluorimetric measurements were done using an Olympus Fluoview 200 laser scanning confocal system (Olympus America, Inc.) mounted on an inverted IX70 Olympus microscope, equipped with a Â60 oil immersion objective (numerical aperture 0.17). X-Y plane images (resolution 800 Â 600 pixels) were acquired every 1.6 s and stored in the multi-TIFF file format,.
For ratiometric measurements, cells were loaded with the acetoxymethyl ester form of Fura-2 (2.5 Amol/L Fura-2 AM, 45 min at 37jC) and imaged at 0.8-s intervals using a monochromator system attached to a TE-2000 Nikon inverted microscope with a Fluor Â20 objective. Images were acquired using an enhanced charge-coupled device camera and Metafluor software (Universal Imaging Corporation).
For experiments on cells grown in monolayer, B-TECs were seeded on glass gelatin-coated coverslips at a density of 50,000 cells in DMEM containing 5% FCS 1 day before the experiments. For experiments done on capillary-like structures, B-TECs were seeded at a density of 15 Â 10 4 cells onto Matrigel-coated glass coverslips in DMEM medium containing 0.25% bovine serum albumin and 5% of FCS 12 h before the experiments. For calcium measurements, the cells were loaded with Fluo-3 AM (2 Amol/L, 30 min, 37jC) and excited by a 488 nm, 20 mW argon-ion laser. Emission signals were filtered by a 510 to 540 nm bandpass filter and detected with the scanning head.
During the experiments, B-TECs were maintained in standard Tyrode solution of the following composition (in mmol/L): NaCl, 154; KCl, 4; CaCl 2 , 2; MgCl 2 , 1; HEPES, 5; glucose, 5.5; and NaOH (pH 7.35). Cells were continuously bathed with a microperfusion system (inner pipette diameter 200 Am); for experiments in calcium-free conditions, the external solution was modified omitting the CaCl 2 salt from the formulation and adding the Ca 2+ chelator EGTA (5 mmol/L). ROIs with a minimum of three detectable cells and without any connection between tubules were considered ''early not organized capillaries'' structures (Fig. 3A) ; on the other hand, we considered ''more mature capillary-like'' structures well connected with each other in a structured network (Fig. 3C) .
For Fura-2 ratiometric measurements, single cells or entire capillary-like structures were selected for each image sequence with Metafluor software (Universal Imaging Corporation). Cytosolic free Ca 2+ i was expressed as a ratio of emitted fluorescence, corresponding to excitation wavelengths of 340 and 380 nm.
Clampfit software was used to further analyze both Fluo-3 and Fura-2 measurements. In particular, we used the agonistinduced slope change as a quantitative criterion to distinguish a response to an agonist from the noise.
One-way ANOVA was done to analyze data sets. Post hoc tests were used to determine statistically significant differences among the groups (Student-Newman-Keuls test). The level of significance was P < 0.05. To compare the percentage of Ca 2+ i responses to AA, ETYA, and ATP at different steges of angiogenesis in vitro, a nonparametric unpaired t test (Wilcoxon-Mann-Whitney) was used as a scoring method. The level of significance was P < 0.05.
